Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
| ▸ | CDC25C | P30307 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18937487 | 0.78 | BRD4 (0.35) | LMNAMCOLN3POLBHTTALDH1A1 | |
| SCHEMBL23762804 | 0.76 | ALDH1A1 (0.31) | LMNAALDH1A1 | |
| SCHEMBL24616657 | 0.72 | — | — | |
| SCHEMBL14072324 | 0.68 | ALDH1A1 (0.35) | LMNAALDH1A1 | |
| SCHEMBL10234059 | 0.65 | BRD4 (0.43) | LMNAALDH1A1L3MBTL1 | |
| SCHEMBL9117924 | 0.65 | BRD4 (0.33) | LMNAPOLBALDH1A1L3MBTL1 | |
| SCHEMBL20577678 | 0.65 | P2RX3 (0.45) | — | |
| SCHEMBL23762803 | 0.64 | — | — | |
| SCHEMBL19012502 | 0.64 | FAAH (0.34) | LMNAALDH1A1 | |
| SCHEMBL12931774 | 0.64 | RGS4 (0.32) | LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220314-A1 | POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE | Sony Group Corporation (JP) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220314-A1 | POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE | H1-0, POLM, H1-2 | LMNA 34/4885MCOLN3 1814/4885POLB 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.